Impact of astrocytic C3-production on neuronal mitochondrial dysfunction in tauopathy mouse models
Chenxu Lei, Bocheng Zhang, Junji YamaguchiiD, Risako Tamura, Xingyu Cao, Yunhui Liu, Masahide SekiiD, Yutaka SuzukiiD, Kuninori SuzukiiD, Isei TanidaiD, Yasuo UchiyamaiD, Tatsuhiro HisatsuneiD
Abstract
Neuronal mitochondrial dysfunction is associated with cognitive decline in neurodegenerative disorders such as Alzheimers Disease (AD). In this study, multiple pieces of evidence proved that phosphorylated tau (p-Tau) caused mitochondrial swelling and dysfunction in neurons. In a novel in vitro newborn neurons culture system, we discovered mitochondrial swelling and dysfunction were associated with increased p-Tau, leading to necroptosis activation, which was induced by Complement C3 (C3) produced from activated astrocytes. In the in vivo tauopathy mouse models, the effects of astrocytic C3 on tau-associated mitochondrial dysfunction and necroptosis were also discovered in hippocampal newborn neurons, and we directly showed that p-Tau aggregation was associated with mitochondria swelling in the hippocampal neurons by electron microscopy analysis. In addition, we proved the ability of compound anserine, which can block Tak1-Ikk dependent NF-{kappa}B activation, to further down-regulate astrocytic C3 production and alleviate neuronal mitochondrial dysfunction in vitro and in vivo, respectively. Down-regulation of astrocyte C3-production by anserine could also rescue mortality as well as cognitive and motor functions. Our findings first reported the contribution of p-Tau on neuronal mitochondrial dysfunction and proposed the therapies that down-regulate astrocytic C3 production have a potential role in alleviating this neurotoxic effect.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial complex III-derived ROS amplify immunometabolic changes in astrocytes and promote dementia pathology
Daniel Barnett, Till S. Zimmer, … Adam L. Orr·Nature MetabolismPeer-reviewed·Nov 4, 2025
- Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Male and Female Mice
Andrea Stojakovic, Su-Youne Chang, … Eugenia V. Trushina·Journal of Alzheimer s DiseasePeer-reviewed·Dec 1, 2020
- Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy
Haneen Makhlouf, Angela O. Dorigatti, … Verónica Galván·bioRxiv·Sep 14, 2026
- Pharmacological restoration of deficits in mitochondrial trafficking rescues aberrant axonal activity in tauopathy
Marie H. Sabec, Oliver R Adam, Michael C. Ashby·bioRxiv·May 2, 2025
- Complement C3aR deletion does not attenuate neurodegeneration in a tauopathy model or alter acute inflammation-induced gene expression changes in the brain
Yuanyuan Wang, Shristi Pandey, … Jesse E. Hanson·bioRxiv·Jun 16, 2025
- Targeting mTOR restores tau-induced metabolic, mitochondrial, and cognitive deficits in a tauopathy mouse model
Zhi Tang, Min Guo, … Xiaolan Qi·bioRxiv·Nov 24, 2024